Si‐Lin Koo

3.3k total citations
28 papers, 535 citations indexed

About

Si‐Lin Koo is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Cancer Research. According to data from OpenAlex, Si‐Lin Koo has authored 28 papers receiving a total of 535 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Oncology, 9 papers in Pulmonary and Respiratory Medicine and 7 papers in Cancer Research. Recurrent topics in Si‐Lin Koo's work include Cancer Immunotherapy and Biomarkers (11 papers), Cancer-related cognitive impairment studies (6 papers) and Cancer Genomics and Diagnostics (6 papers). Si‐Lin Koo is often cited by papers focused on Cancer Immunotherapy and Biomarkers (11 papers), Cancer-related cognitive impairment studies (6 papers) and Cancer Genomics and Diagnostics (6 papers). Si‐Lin Koo collaborates with scholars based in Singapore, United States and United Kingdom. Si‐Lin Koo's co-authors include Rebecca Dent, Hirofumi Matsumoto, Puay Hoon Tan, Jabed Iqbal, Joe Yeong, Aye Aye Thike, Huihua Li, Iain Beehuat Tan, Yoon Sim Yap and Han Chong Toh and has published in prestigious journals such as Nature Communications, Journal of Clinical Oncology and Cancer Research.

In The Last Decade

Si‐Lin Koo

23 papers receiving 527 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Si‐Lin Koo Singapore 11 299 165 147 141 130 28 535
Rico D. Bense Netherlands 8 298 1.0× 166 1.0× 153 1.0× 141 1.0× 177 1.4× 9 508
Betül T. Yesilyurt Belgium 8 194 0.6× 89 0.5× 57 0.4× 140 1.0× 184 1.4× 9 452
S. Mariucci Italy 9 198 0.7× 63 0.4× 107 0.7× 82 0.6× 146 1.1× 18 341
Alexander B. Sibley United States 12 171 0.6× 80 0.5× 43 0.3× 71 0.5× 124 1.0× 27 393
Giulia Mazzaschi Italy 11 444 1.5× 254 1.5× 166 1.1× 96 0.7× 130 1.0× 54 634
Valentina Tuninetti Italy 12 271 0.9× 100 0.6× 111 0.8× 125 0.9× 186 1.4× 28 600
Anne-Sophie Heimes Germany 14 340 1.1× 113 0.7× 126 0.9× 146 1.0× 170 1.3× 40 558
Raja Mudad United States 15 174 0.6× 133 0.8× 79 0.5× 46 0.3× 44 0.3× 35 435
Christos Mikropoulos United Kingdom 11 286 1.0× 179 1.1× 33 0.2× 101 0.7× 175 1.3× 21 483
Cristina Migali Italy 12 376 1.3× 86 0.5× 198 1.3× 66 0.5× 91 0.7× 17 511

Countries citing papers authored by Si‐Lin Koo

Since Specialization
Citations

This map shows the geographic impact of Si‐Lin Koo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Si‐Lin Koo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Si‐Lin Koo more than expected).

Fields of papers citing papers by Si‐Lin Koo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Si‐Lin Koo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Si‐Lin Koo. The network helps show where Si‐Lin Koo may publish in the future.

Co-authorship network of co-authors of Si‐Lin Koo

This figure shows the co-authorship network connecting the top 25 collaborators of Si‐Lin Koo. A scholar is included among the top collaborators of Si‐Lin Koo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Si‐Lin Koo. Si‐Lin Koo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Li, Shamin, Si‐Lin Koo, Aaron C. Tan, et al.. (2022). Bystander CD4 + T cells infiltrate human tumors and are phenotypically distinct. OncoImmunology. 11(1). 2012961–2012961. 17 indexed citations
3.
Han, Shuting, et al.. (2022). The distinct clinical trajectory, metastatic sites, and immunobiology of microsatellite-instability-high cancers. Frontiers in Genetics. 13. 933475–933475. 9 indexed citations
4.
Fu, Siqing, Udai Banerji, Philippe L. Bédard, et al.. (2022). Abstract CT503: A phase I/Ib study of the safety and preliminary efficacy of NZV930 alone and in combination with spartalizumab and/or taminadenant in patients (pts) with advanced malignancies. Cancer Research. 82(12_Supplement). CT503–CT503. 6 indexed citations
5.
Lam, Jian Hang, Michelle Hong, Si‐Lin Koo, et al.. (2021). CD30+OX40+ Treg is associated with improved overall survival in colorectal cancer. Cancer Immunology Immunotherapy. 70(8). 2353–2365. 24 indexed citations
6.
Zhu, Guanhua, Yu Amanda Guo, Polly Poon, et al.. (2021). Tissue-specific cell-free DNA degradation quantifies circulating tumor DNA burden. Nature Communications. 12(1). 2229–2229. 44 indexed citations
7.
Ragulan, Chanthirika, Katherine Eason, Elisa Fontana, et al.. (2019). Analytical Validation of Multiplex Biomarker Assay to Stratify Colorectal Cancer into Molecular Subtypes. Scientific Reports. 9(1). 7665–7665. 29 indexed citations
8.
Ng, Terence, Yin Ting Cheung, Hui Ling Yeo, et al.. (2018). Distinct and heterogeneous trajectories of self‐perceived cognitive impairment among Asian breast cancer survivors. Psycho-Oncology. 27(4). 1185–1192. 46 indexed citations
9.
Ng, D. C. K., Ryan Tan, Rehena Sultana, et al.. (2018). Prevalence of vitamin D deficiency in Chinese patients with early stage colorectal cancer. Annals of Oncology. 29. ix41–ix41.
10.
Chae, Jung‐woo, Terence Ng, Maung Shwe, et al.. (2018). Association of mitochondrial DNA content in peripheral blood with cancer-related fatigue and chemotherapy-related cognitive impairment in early-stage breast cancer patients: a prospective cohort study. Breast Cancer Research and Treatment. 168(3). 713–721. 21 indexed citations
11.
Schwartz, Sarit, Yuan Tian, Franco Cecchi, et al.. (2018). The prognostic role of microsatellite status, tumor mutational burden, and protein expression in CRC.. Journal of Clinical Oncology. 36(4_suppl). 572–572. 2 indexed citations
13.
Ng, Terence, Jung‐woo Chae, Hui Ling Yeo, et al.. (2017). A web-based tool to predict chemotherapy-associated cognitive impairment during survivorship.. Journal of Clinical Oncology. 35(15_suppl). e21609–e21609. 1 indexed citations
14.
Chua, Clarinda, Matthew Chau Hsien Ng, Anna Gan, et al.. (2017). Individualised multiplexed circulating tumour DNA assays for monitoring of tumour presence in patients after colorectal cancer surgery. Scientific Reports. 7(1). 40737–40737. 44 indexed citations
15.
Ng, Terence, Hui Ling Yeo, Maung Shwe, et al.. (2017). A genome-wide association study (GWAS) meta-analysis of chemotherapy-associated cognitive impairment (CACI) in Asian early-stage breast cancer patients (ESBC).. Journal of Clinical Oncology. 35(15_suppl). 10096–10096. 1 indexed citations
16.
Matsumoto, Hirofumi, Aye Aye Thike, Huihua Li, et al.. (2016). Increased CD4 and CD8-positive T cell infiltrate signifies good prognosis in a subset of triple-negative breast cancer. Breast Cancer Research and Treatment. 156(2). 237–247. 121 indexed citations
17.
Adusumalli, Swarnaseetha, et al.. (2015). Assessment of Web-Based Consumer Reviews as a Resource for Drug Performance. Journal of Medical Internet Research. 17(8). e211–e211. 9 indexed citations
18.
Matsumoto, Hirofumi, Si‐Lin Koo, Rebecca Dent, Puay Hoon Tan, & Jabed Iqbal. (2015). Role of inflammatory infiltrates in triple negative breast cancer. Journal of Clinical Pathology. 68(7). 506–510. 94 indexed citations
19.
Koo, Si‐Lin, Jin Wen, Axel M. Hillmer, et al.. (2013). Current and emerging surveillance strategies to expand the window of opportunity for curative treatment after surgery in colorectal cancer. Expert Review of Anticancer Therapy. 13(4). 439–450. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026